bluebird bio (BLUE) Jumps: Stock Adds 27.3% in Session - Tale of the Tape

bluebird bio, Inc. BLUE was a big mover last session, as its shares rose over 27% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the healthcare company, as the stock is now trading above the volatile price range of $17.69 to $21.41 in the past one-month timeframe.

In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

bluebird bio currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Better-ranked stocks in the medical sector include TrovaGene, Inc. TROV, ZIOPHARM Oncology, Inc. ZIOP and Agenus Inc. AGEN. All three sport a Zacks Rank #2 (Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
AGENUS INC AGEN: Free Stock Analysis Report
 
BLUEBIRD BIO BLUE: Free Stock Analysis Report
 
TROVAGENE INC TROV: Get Free Report
 
ZIOPHARM ONCLGY ZIOP: Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!